EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Artificial Intelligence‐Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction‐Associated Steatotic Liver Disease?

Tugce Ozlu Karahan, Emre Batuhan Kenger, Yusuf Yilmaz

Journal of Human Nutrition and Dietetics · 2025-04 · 38 (2)

DOI: 10.1111/jhn.70033 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing global health concern. Effective management of this condition relies heavily on lifestyle modifications and dietary interventions. In this study, we sought to evaluate the dietary plans for MASLD generated by ChatGPT (GPT‐4o) according to current guideline recommendations. Methods ChatGPT was used to create single‐day meal plans for 48 simulated patients with MASLD, tailored to individual characteristics such as age, gender, height, weight and transient elastography parameters. The plans were assessed for appropriateness according to disease‐specific guidelines. Results The mean energy content of the menus planned by ChatGPT was 1596.9 ± 141.5 kcal with a mean accuracy of 91.3 ± 11.0%, and fibre content was 22.0 ± 0.6 g with a mean accuracy of 88.1 ± 2.5%. However, they exhibited elevated levels of protein, fat and saturated fat acids. Conversely, the carbohydrate content was lower. ChatGPT recommended weight loss for obese patients but did not extend this advice to normal‐weight and overweight individuals. Notably, recommendations for a Mediterranean diet and physical activity were absent. Conclusions ChatGPT shows potential in developing dietary plans for MASLD management. However, discrepancies in macronutrient distributions and the omission of key evidence‐based recommendations highlight the need for further refinement. To enhance the effectiveness of AI tools in dietary recommendations, alignment with established guidelines must be improved.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →